Skip to content

Study on the Diagnostic Value of High-frequency Ultrasound Combined with Low-frequency Ultrasound for Liver Fibrosis: A Cross-sectional Study

Study on the Diagnostic Value of High-frequency Ultrasound Combined with Low-frequency Ultrasound for Liver Fibrosis: A Cross-sectional Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500111788
Enrollment
Unknown
Registered
2025-11-05
Start date
2025-11-10
Completion date
Unknown
Last updated
2025-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver fibrosis

Interventions

Gold Standard:Liver biopsy pathology or liver surgery pathology
Index test:The combined use of high-frequency ultrasound and low-frequency ultrasound

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 18 - 75 years; 2. Patients with chronic liver disease: chronic viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, autoimmune liver disease, hereditary liver disease, drug- or toxin-induced liver disease, other types, or unclear or mixed liver disease; 3. Patients who need to undergo liver biopsy or surgical pathology and agree to high-frequency and low-frequency ultrasound examination; 4. Able to provide complete clinical data and follow-up information.

Exclusion criteria

Exclusion criteria: 1. Unable to obtain standard liver images, such as when the liver is <=4 cm from the body surface, or after major liver resection, etc.; 2. Patients who cannot cooperate with liver puncture biopsy or surgery, such as those with severe systemic diseases, etc.; 3. Women who are pregnant or breastfeeding.

Design outcomes

Primary

MeasureTime frame
sensibility;negative predictive value(NPV);positive predictive value(PPV);Specificity;

Secondary

MeasureTime frame
Accuracy;

Countries

China

Contacts

Public ContactShuyuan Guo

Peking University Shenzhen Hospital

1010541701@qq.com+86 755 83923333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026